Back to Results

BIO-Key International Inc (BKYI)

BIO-key International, Inc. is a NASDAQ-listed common stock issuer based in Holmdel, New Jersey. The company develops and markets fingerprint identification biometric technology and software, along with enterprise identity and access management solutions for commercial, government, and education customers in the United States and abroad. Its product line includes BIO-key PortalGuard and PortalGuard IDaaS, a cloud-based identity platform designed to work with cloud and on-premise applications, services, and cloud hosts, as well as Windows device authentication. BIO-key also provides BIO-key VST and WEB-key, civil and large-scale identity infrastructure solutions, and fingerprint scanners and readers sold under brand names such as SideSwipe, PIV Pro, EcoID II, and SidePass. Founded in 1993 and formerly known as SAC Technologies, the company adopted the BIO-key International name in 2002.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-BKYI
$7.02
61.4% Upside
Bargain
$20
359.8% Upside
Bargain
Weak
—
—
—
0.0%
August 17, 2026
-0.7x
1.0x
0.7x
4.721 M
680.027 K
13.0%
90.7%
-25.7
—
63.4%
Valuation • Fair Value

BIO-Key International Inc (NASDAQ-BKYI) Fair Value by Valuation Model

Compare the primary fair value estimate for BIO-Key International Inc (NASDAQ-BKYI) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$7.02

Estimated upside of 61.4% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

NM

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$7.02

Comparable-company valuation reference.

Analyst Price Target

$20

Analysts imply upside of 359.8%.

How to read these valuation models

Use this section to compare the primary fair value estimate for BIO-Key International Inc (NASDAQ-BKYI) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for BIO-Key International Inc (NASDAQ-BKYI)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

6.476 M

Current operating scale indicator.

Revenue Forecast

9 M

Forward revenue estimate.

EBITDA

-3.52 M

Current operating profitability reference.

EBITDA Forecast

Not available

Data is currently unavailable.

How to read profitability and growth

This section helps investors review BIO-Key International Inc (NASDAQ-BKYI) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for BIO-Key International Inc (NASDAQ-BKYI)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

4

Mid-range quality score.

Beneish M-Score

-3.24

No elevated caution signal from this screen.

Altman Z-Score

-25.7

Lower score that deserves closer risk review.

FCF / Net Income

63.4%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for BIO-Key International Inc (NASDAQ-BKYI). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for BIO-Key International Inc (NASDAQ-BKYI)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 17, 2026

Days to Earnings

27

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for BIO-Key International Inc (NASDAQ-BKYI), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

BIO-Key International Inc (NASDAQ-BKYI) Stock Forecast & Technical Outlook

Review BIO-Key International Inc (NASDAQ-BKYI) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for BIO-Key International Inc (NASDAQ-BKYI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for BIO-Key International Inc (NASDAQ-BKYI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for BIO-Key International Inc (NASDAQ-BKYI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for BIO-Key International Inc (NASDAQ-BKYI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for BIO-Key International Inc (NASDAQ-BKYI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for BIO-Key International Inc (NASDAQ-BKYI)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Not available

Analyst recommendation data for BIO-Key International Inc (NASDAQ-BKYI) is not currently available.

Buy 0
Hold 0
Sell 0
FAQ • Fast Investor Answers

BIO-Key International Inc (NASDAQ-BKYI) Stock FAQ

Quick answers about BIO-Key International Inc (NASDAQ-BKYI) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$7.02
Estimated upside 61.4%
Valuation Rating
Undervalued
Estimated upside of 61.4%
Analyst Target
$20
Implied upside 359.8%
Financial Health
Weak
Current financial-health read

The current fair value estimate for BIO-Key International Inc (NASDAQ-BKYI) is $7.02. This implies an estimated upside of 61.4% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 61.4% versus the current market price.

The available analyst price target for BIO-Key International Inc (NASDAQ-BKYI) is $20. The analyst target implies estimated upside of 359.8%.

The current financial health read for BIO-Key International Inc (NASDAQ-BKYI) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for BIO-Key International Inc (NASDAQ-BKYI) is August 17, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for BIO-Key International Inc (NASDAQ-BKYI) is -0.7x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for BIO-Key International Inc is 4.721 M.

The current enterprise value listed for BIO-Key International Inc is 680.027 K. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for BIO-Key International Inc is NASDAQ-BKYI, and the stock is listed on NASDAQ.

BIO-Key International Inc (NASDAQ-BKYI) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for BIO-Key International Inc is 13.0%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for BIO-Key International Inc is 90.7%. Free float helps investors understand how much of the share base is available for public trading.

Similar Software Stocks on NASDAQ View more

Microsoft Corporation (MSFT) Microsoft Corporation (MSFT)
Palantir Technologies Inc (PLTR) Palantir Technologies Inc (PLTR)
Palo Alto Networks Inc (PANW) Palo Alto Networks Inc (PANW)
CrowdStrike Holdings Inc (CRWD) CrowdStrike Holdings Inc (CRWD)
Applovin Corp (APP) Applovin Corp (APP)
Fortinet Inc (FTNT) Fortinet Inc (FTNT)
Datadog Inc (DDOG) Datadog Inc (DDOG)
Adobe Systems Incorporated (ADBE) Adobe Systems Incorporated (ADBE)
Cadence Design Systems Inc (CDNS) Cadence Design Systems Inc (CDNS)
Intuit Inc (INTU) Intuit Inc (INTU)
Synopsys Inc (SNPS) Synopsys Inc (SNPS)
Nebius Group NV (NBIS) Nebius Group NV (NBIS)
Autodesk Inc (ADSK) Autodesk Inc (ADSK)
Roper Technologies Inc (ROP) Roper Technologies Inc (ROP)
Workday Inc (WDAY) Workday Inc (WDAY)
Strategy Inc (MSTR) Strategy Inc (MSTR)
Strategy Inc Preferred (STRK) Strategy Inc Preferred (STRK)
Strategy Inc Preferred D (STRD) Strategy Inc Preferred D (STRD)
Strategy Inc Preferred Series A (STRC) Strategy Inc Preferred Series A (STRC)
Strategy Inc Preferred Series F (STRF) Strategy Inc Preferred Series F (STRF)
Zoom Video Communications Inc (ZM) Zoom Video Communications Inc (ZM)
Atlassian Corp Plc (TEAM) Atlassian Corp Plc (TEAM)
Zscaler Inc (ZS) Zscaler Inc (ZS)
Gen Digital Inc (GEN) Gen Digital Inc (GEN)